Fund Holdings — TAKEDA PHARMACEUTICAL CO LTD

Total Portfolio Value
$26.56M
Total Bought
$906.0K
Total Sold
$11.04M
Net Transaction
-$10.14M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
HilleVax, Inc.6,724,0006,724,000011,83513,91952.40%+2,084
Lyell Immunopharma, Inc.(LYEL)0823,317+823,31705271.98%+527
Third Harmonic Bio, Inc.036,835+36,83503791.43%+379
Xilio Therapeutics, Inc.(XLO)1,475,1211,475,12101,1621,4165.33%+254
STANDARD BIOTOOLS INC.(LAB)16,51516,515032290.11%-3
Turnstone Biologics Corp.895,824895,82404994481.69%-51
Equillium, Inc.(EQ)1,824,9771,824,97701,5151,3695.15%-146
Rani Therapeutics Holdings, Inc.(RANI)203,190203,19004392781.05%-161
American Well Corp(AMWL)77,73377,73307375642.12%-173
Shattuck Labs, Inc.(STTK)515,619515,61901,8006242.35%-1,176
Ovid Therapeutics Inc.(OVID)7,531,9967,531,99608,8887,01226.40%-1,876
Wave Life Sciences Ltd.(WVE)1,346,8920-1,346,89211,0450—-11,045
Page 1 of 1
TAKEDA PHARMACEUTICAL CO LTD — 13F Holdings — Q4 2024 | TickerTrail